INS and Hypoglycemia: After glimepiride was replaced with pioglitazone (30 mg/day) for 3 months, his glucose control did not change but his triglyceride, insulin, and inflammatory marker levels decreased (ESM Table 5), with no hypoglycemia or reduced eGFR.